Grant name: Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
Funding organization: National Institutes of Health (NIH)
Total funding amount: $400,000 over two years
Primary objective: Support time-sensitive ancillary studies related to ongoing clinical projects
Key stakeholders: Researchers, clinical project participants
Funding source: NIH
Funding type: Grant
Significance: Enhances scientific content and value of parent projects
Grant frequency: Recurring
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits Other Than Institutions of Higher Education
For-Profit Organizations
Small Businesses
Local Governments
State Governments
County Governments
City or Township Governments
Indian/Native American Tribal Governments (Federally Recognized)
Indian/Native American Tribal Governments (Other than Federally Recognized)
Foreign Organizations (non-domestic entities) are not eligible to apply.
Time-sensitive ancillary studies related to NIAMS mission
Studies that address new research questions not covered in parent projects
Applications must demonstrate scientific merit and innovation.
Direct costs limited to $400,000 over two years
No more than $250,000 in direct costs in any single year
Application due date: December 5, 2025
Must comply with NIH Grants Policy Statement.
Applications must be submitted electronically through Grants.gov.